secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2025-11-28T23:59:59+00:00
Accession:  0001104659-25-116962
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma shareholders approve 1.5M share increase to incentive plan and elect directors
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2021 Incentive Compensation Plan, increasing authorized shares by 1,500,000 and extending term to November 20, 2035.
- Seven directors elected: Iain Dukes, Werner Cautreels, Trafford Clarke, John Leaman, Nikolay Savchuck, M. Teresa Shoemaker, Jack E. Stover.
- Advisory vote on executive compensation approved; company will hold such votes every two years, next at 2027 annual meeting.
- Ratification of KPMG as independent auditor for FY2025 approved with 3,350,178 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925116962/0001104659-25-116962-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925116962/tm2532319d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-116962

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer